93 related articles for article (PubMed ID: 24722942)
1. Neuropilin 1 expression in human aortas, coronaries and the main bypass grafts.
Alattar M; Jiang C; Luan Z; Pan T; Liu L; Li J
Eur J Cardiothorac Surg; 2014 Dec; 46(6):967-73. PubMed ID: 24722942
[TBL] [Abstract][Full Text] [Related]
2. Intimal hyperplasia and expression of transforming growth factor-beta1 in saphenous veins and internal mammary arteries before coronary artery surgery.
Friedl R; Li J; Schumacher B; Hanke H; Waltenberger J; Hannekum A; Stracke S
Ann Thorac Surg; 2004 Oct; 78(4):1312-8. PubMed ID: 15464491
[TBL] [Abstract][Full Text] [Related]
3. Vascular-wall remodeling of 3 human bypass vessels: organ culture and smooth muscle cell properties.
Mekontso-Dessap A; Kirsch M; Guignambert C; Zadigue P; Adnot S; Loisance D; Eddahibi S
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):651-8. PubMed ID: 16515919
[TBL] [Abstract][Full Text] [Related]
4. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
[TBL] [Abstract][Full Text] [Related]
5. Vasomotor response to ergometrine and nitrates of saphenous vein grafts, internal mammary artery grafts, and grafted coronary arteries late after bypass surgery.
Hanet C; Robert A; Wijns W
Circulation; 1992 Nov; 86(5 Suppl):II210-6. PubMed ID: 1424002
[TBL] [Abstract][Full Text] [Related]
6. Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia.
Déglise S; Martin D; Probst H; Saucy F; Hayoz D; Waeber G; Nicod P; Ris HB; Corpataux JM; Haefliger JA
J Vasc Surg; 2005 Jun; 41(6):1043-52. PubMed ID: 15944608
[TBL] [Abstract][Full Text] [Related]
7. p38 MAPK inhibitor, CBS3830 limits vascular remodelling in arterialised vein grafts.
Ge JJ; Zhao ZW; Zhou ZC; Wu S; Zhang R; Pan FM; Abendroth DK
Heart Lung Circ; 2013 Sep; 22(9):751-8. PubMed ID: 23523564
[TBL] [Abstract][Full Text] [Related]
8. Flow capacity of internal mammary artery grafts: early restriction and later improvement assessed by Doppler guide wire. Comparison with saphenous vein grafts.
Akasaka T; Yoshikawa J; Yoshida K; Maeda K; Hozumi T; Nasu M; Shomura T
J Am Coll Cardiol; 1995 Mar; 25(3):640-7. PubMed ID: 7860908
[TBL] [Abstract][Full Text] [Related]
9. Morphologic observations in biologic conduits between aorta and coronary artery.
Spray TL; Roberts WC
Cardiovasc Clin; 1977; 8(2):11-40. PubMed ID: 332366
[TBL] [Abstract][Full Text] [Related]
10. Comparison of response to injury in organ culture of human saphenous vein and internal mammary artery.
Holt CM; Francis SE; Newby AC; Rogers S; Gadsdon PA; Taylor T; Angelini GD
Ann Thorac Surg; 1993 Jun; 55(6):1522-8. PubMed ID: 8512406
[TBL] [Abstract][Full Text] [Related]
11. The no-touch saphenous vein as the preferred second conduit for coronary artery bypass grafting.
Dreifaldt M; Mannion JD; Bodin L; Olsson H; Zagozdzon L; Souza D
Ann Thorac Surg; 2013 Jul; 96(1):105-11. PubMed ID: 23684156
[TBL] [Abstract][Full Text] [Related]
12. Arterial grafts do not counteract target vessel occlusion.
Bartnes K; Hermansen SE; Dahl-Eriksen Ø; Bahar R; Busund R; Sørlie DG; Myrmel T
Eur J Cardiothorac Surg; 2013 Nov; 44(5):e320-4. PubMed ID: 23956270
[TBL] [Abstract][Full Text] [Related]
13. Binding of [3H]-5-hydroxytryptamine to human coronary artery and bypass graft vessels.
Dahm PL; Bodelsson M; Törnebrandt K; Muddle JR; Sykes RM; Yacoub M; Dashwood MR
Cardiovasc Res; 1996 May; 31(5):800-6. PubMed ID: 8763410
[TBL] [Abstract][Full Text] [Related]
14. A Gbetagamma inhibitor reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Petrofski JA; Hata JA; Williams ML; Parsa CJ; Thompson RB; Hanish SI; Gehrig TR; Koch WJ; Milano CA
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1683-90. PubMed ID: 16308016
[TBL] [Abstract][Full Text] [Related]
15. Everolimus attenuates neointimal hyperplasia in cultured human saphenous vein grafts.
Semsroth S; Stigler RG; Bernecker OY; Ruttmann-Ulmer E; Troppmair J; Macfelda K; Bonatti JO; Laufer G
Eur J Cardiothorac Surg; 2009 Mar; 35(3):515-20. PubMed ID: 19167904
[TBL] [Abstract][Full Text] [Related]
16. Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts.
Khot UN; Friedman DT; Pettersson G; Smedira NG; Li J; Ellis SG
Circulation; 2004 May; 109(17):2086-91. PubMed ID: 15123539
[TBL] [Abstract][Full Text] [Related]
17. A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts.
Desai ND; Cohen EA; Naylor CD; Fremes SE;
N Engl J Med; 2004 Nov; 351(22):2302-9. PubMed ID: 15564545
[TBL] [Abstract][Full Text] [Related]
18. Computational model of blood flow in the aorto-coronary bypass graft.
Sankaranarayanan M; Chua LP; Ghista DN; Tan YS
Biomed Eng Online; 2005 Mar; 4():14. PubMed ID: 15745458
[TBL] [Abstract][Full Text] [Related]
19. [Expression of early growth response gene-1 and its correlative genes in autogenous vein graft and significance thereof: an experiment with rats].
Liu CW; Hu XH; Yang J; Zhang Q; Zhang XS; Duan ZQ
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(48):3414-8. PubMed ID: 16409863
[TBL] [Abstract][Full Text] [Related]
20. High-pressure distention of the saphenous vein during preparation results in increased markers of inflammation: a potential mechanism for graft failure.
Khaleel MS; Dorheim TA; Duryee MJ; Durbin HE; Bussey WD; Garvin RP; Klassen LW; Thiele GM; Anderson DR
Ann Thorac Surg; 2012 Feb; 93(2):552-8. PubMed ID: 22206954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
